Understand the source comparison
Does AHK-Cu Help Alopecia Support Research?: Study Design Comparison
Primary Endpoint Hair density increase (anagen extension) Hair density stabilization (DHT suppression) Follicle anchoring force, matrix thickness, shedding rate reduction AHK-Cu targets structural integrity—distinct endpoint requiring different measurement Opt
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Primary Endpoint
- Hair density increase (anagen extension)
- Hair density stabilization (DHT suppression)
- Follicle anchoring force, matrix thickness, shedding rate reduction
- AHK-Cu targets structural integrity—distinct endpoint requiring different measurement
- Optimal Model System
- Androgenetic alopecia (male/female), telogen effluvium
- Androgenetic alopecia (male pattern only)
- Scarring alopecia, traction alopecia, post-inflammatory regrowth, age-related atrophy
- Copper peptides apply across alopecia subtypes that lack hormonal or immune drivers
- Typical Response Timeline
- 12–24 weeks for measurable density change
- 6–12 months for follicle miniaturization stabilization
- 8–16 weeks for matrix remodeling and tensile strength improvement
- Structural changes manifest faster than hormonal modulation but slower than vasodilation
- Synergy Potential
- High with anti-androgens (complementary mechanisms)
- High with vasodilators (complementary mechanisms)
- High with all classes—addresses structural pathway none of them target
- Combination protocols capturing hormone, vasodilation, and structure may outperform monotherapy
- Measurement Tools Required
- Trichoscopy, folliscope density counts
- Trichoscopy, DHT serum levels
- Tensile testing, dermal ultrasound, MMP immunohistochemistry, collagen I/III expression
- Standard alopecia metrics miss AHK-Cu's structural effects—protocol design must include matrix biomarkers